InterMedSo Luxembourg: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
InterMedSo Luxembourg
Largest movements
- Current investments +€130,000
up €130,000 (+16.3%), from €800,000 to €930,000
- Receivables within one year -€56,550
down €56,550 (-18.1%), from €311,850 to €255,300
of which Other amounts receivable: -€54,727
- Cash +€50,338
up €50,338 (+47.4%), from €106,155 to €156,493
mainly Net result for the year (+€57,847) and Receivables within one year (+€56,550)
- Receivables after one year -€45,218
down €45,218 (-8.2%), from €548,178 to €502,960
- Profit (loss) carried forward +€57,847
up €57,847, from €0 to €57,847
- Gross operating margin -€66,195
down €66,195 (-40.7%), from €162,599 to €96,404
- Purchases and services +€63,628
up €63,628 (+23.1%), from €275,929 to €339,558
- Write-downs +€26,437
new in 2025: €26,437
- Financial charges +€19,952
up €19,952 (+5,210%), from €383 to €20,334
of which Non-recurring financial charges: +€19,941
- Other operating charges -€9,294
down €9,294 (-24.6%), from €37,717 to €28,424
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,998,954 | €2,054,585 | +€55,631 | +2.8% |
| Fixed assets | 21/28 | €229,461 | €209,417 | -€20,044 | -8.7% |
| Intangible fixed assets | 21 | €128 | - | -€128 | |
| Financial fixed assets | 28 | €229,333 | €209,417 | -€19,916 | -8.7% |
| Current assets | 29/58 | €1,769,493 | €1,845,169 | +€75,676 | +4.3% |
| Amounts receivable after more than one year | 29 | €548,178 | €502,960 | -€45,218 | -8.2% |
| Other amounts receivable | 291 | €548,178 | €502,960 | -€45,218 | -8.2% |
| Amounts receivable within one year | 40/41 | €311,850 | €255,300 | -€56,550 | -18.1% |
| Trade receivables | 40 | €2,326 | €503 | -€1,823 | -78.4% |
| Other amounts receivable | 41 | €309,524 | €254,797 | -€54,727 | -17.7% |
| Current investments | 50/53 | €800,000 | €930,000 | +€130,000 | +16.3% |
| Cash at bank and in hand | 54/58 | €106,155 | €156,493 | +€50,338 | +47.4% |
| Deferred charges and accrued income | 490/1 | €3,310 | €416 | -€2,895 | -87.4% |
| Total equity and liabilities | 10/49 | €1,998,954 | €2,054,585 | +€55,631 | +2.8% |
| Equity | 10/15 | €1,985,179 | €2,043,026 | +€57,847 | +2.9% |
| Contributions | 10/11 | €1,585,179 | €1,585,179 | = | 0.0% |
| Capital | 10 | €1,585,179 | €1,585,179 | = | 0.0% |
| Reserves | 13 | €400,000 | €400,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €0 | €57,847 | +€57,847 | |
| Amounts payable | 17/49 | €13,775 | €11,559 | -€2,216 | -16.1% |
| Amounts payable within one year | 42/48 | €11,761 | €10,447 | -€1,314 | -11.2% |
| Trade debts | 44 | €7,521 | €7,839 | +€318 | +4.2% |
| Suppliers | 440/4 | €7,521 | €7,839 | +€318 | +4.2% |
| Taxes, remuneration and social security | 45 | €2,206 | €711 | -€1,495 | -67.8% |
| Taxes | 450/3 | €2,206 | €711 | -€1,495 | -67.8% |
| Accrued charges and deferred income | 492/3 | €2,014 | €1,112 | -€902 | -44.8% |
| Membership fees, donations, legacies and grants | 73 | €435,645 | €435,825 | +€180 | 0.0% |
| Non-recurring operating income | 76A | - | €137 | +€137 | |
| Goods, raw materials, services and sundry goods | 60/61 | €275,929 | €339,558 | +€63,628 | +23.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €430 | €128 | -€301 | -70.1% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €26,437 | +€26,437 | |
| Other operating charges | 640/8 | €37,717 | €28,424 | -€9,294 | -24.6% |
| Gross operating margin | 9900 | €162,599 | €96,404 | -€66,195 | -40.7% |
| Operating profit (loss) | 9901 | €124,452 | €41,415 | -€83,037 | -66.7% |
| Financial income | 75/76B | €30,648 | €36,767 | +€6,118 | +20.0% |
| Recurring financial income | 75 | €30,648 | €36,767 | +€6,118 | +20.0% |
| Financial charges | 65/66B | €383 | €20,334 | +€19,952 | +5,210% |
| Recurring financial charges | 65 | €383 | €394 | +€11 | +2.8% |
| Non-recurring financial charges | 66B | - | €19,941 | +€19,941 | |
| Profit (loss) for the period before taxes | 9903 | €154,717 | €57,847 | -€96,870 | -62.6% |
| Profit (loss) for the period | 9904 | €154,717 | €57,847 | -€96,870 | -62.6% |
| Profit (loss) for the period to be appropriated | 9905 | €154,717 | €57,847 | -€96,870 | -62.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.